Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Eliksa Therapeutics Logo
Eliksa Therapeutics Growth Score
54
CB Rank
248186
Heat Score
35
Eliksa Therapeutics is a biotechnology company that develops regenerative medicine.
Founded
obfuscation
PrivateVenture - Series Unknown Doylestown, Pennsylvania, United States1-10 www.eliksa.com
Biotechnology
Medical
Overview

Eliksa Therapeutics
Growth Score
54
Heat Score
35

Growth Score54
-9 pts
in past quarter
Heat Score 35
-15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Eliksa Therapeutics

CB Rank
248186
Eliksa Therapeutics is a biotechnology company that develops regenerative medicine.
Founded
obfuscation
PrivateVenture - Series Unknown Doylestown, Pennsylvania, United States1-10 www.eliksa.com
Biotechnology
Medical

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Eliksa Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Founders  Armen Karamanian, Jane Hollingsworth
Contact Email hello@eliksa.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Insight

See this Growth Insight
Eliksa Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

ELK-003
An investigational ophthalmic drug in eye drop form designed to treat ocular symptoms of Epidermolysis Bullosa, a rare genetic disorder.
cGMP Regenerative Medicine Manufacturing Services
Specialized processing and sterilization of proprietary biological products in a cGMP facility for therapeutic applications.

Research & Development

Eliksa Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Eliksa Therapeutics Logo
Venture Round - Eliksa Therapeutics
5
obfuscation
DEBRA ResearchVenture - Series Unknown
obfuscation
Venture Round - Eliksa Therapeutics Logo
Venture Round - Eliksa Therapeutics
5
obfuscation
DEBRA ResearchVenture - Series Unknown
obfuscation
Venture Round - Eliksa Therapeutics Logo
Venture Round - Eliksa Therapeutics
5
obfuscation
DEBRA ResearchVenture - Series Unknown
obfuscation
Venture Round - Eliksa Therapeutics Logo
Venture Round - Eliksa Therapeutics
5
obfuscation
DEBRA ResearchVenture - Series Unknown
obfuscation
Venture Round - Eliksa Therapeutics Logo
Venture Round - Eliksa Therapeutics
5
obfuscation
DEBRA ResearchVenture - Series Unknown

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Eliksa Therapeutics Logo
Venture Round - Eliksa Therapeutics
5
obfuscation
DEBRA ResearchVenture - Series Unknown
obfuscation
Venture Round - Eliksa Therapeutics Logo
Venture Round - Eliksa Therapeutics
5
obfuscation
DEBRA ResearchVenture - Series Unknown
obfuscation
Venture Round - Eliksa Therapeutics Logo
Venture Round - Eliksa Therapeutics
5
obfuscation
DEBRA ResearchVenture - Series Unknown
obfuscation
Venture Round - Eliksa Therapeutics Logo
Venture Round - Eliksa Therapeutics
5
obfuscation
DEBRA ResearchVenture - Series Unknown
obfuscation
Venture Round - Eliksa Therapeutics Logo
Venture Round - Eliksa Therapeutics
5
obfuscation
DEBRA ResearchVenture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 3

Employee Profiles

News

News and Press

News•Oct 29, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 11, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 12, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$45.9KThis year, Eliksa Therapeutics is projected to spend $45.9K on IT, according to Aberdeen.

Active Website Tech Count

24Eliksa Therapeutics is actively using 24 technologies for its website, according to BuiltWith. These include SSL by Default, Viewport Meta, and  LetsEncrypt.

Total IP

3The intellectual property of Eliksa Therapeutics includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Eliksa Therapeutics's headquarters? Eliksa Therapeutics is located in Doylestown, Pennsylvania, United States.Who invested in Eliksa Therapeutics? Eliksa Therapeutics has 5 investors including ABE and  DEBRA Research.When was the last funding round for Eliksa Therapeutics? Eliksa Therapeutics closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Eliksa Therapeutics's competitors? Alternatives and possible competitors to Eliksa Therapeutics may include Lineage Cell Therapeutics, Castle Creek Biosciences, and  Krystal Biotech.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f7db04b 1)
|